IP Library › Assignment 050403/0693
Patent Assignment
Reel/Frame 050403/0693

Assignment of Assignor's Interest

Recorded: 2019-09-17 Pages: 3
Assignors
MILLER, THOMAS A.
Executed: 2017-04-05
PAPAIOANNOU, NIKOLAOS
Executed: 2017-04-05
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Anti-Fibrotic Compounds
Application: 16/483,341 →
Publication: US 2020/0055814
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 17, 2019
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: CERTA THERAPEUTICS PTY LTD.
Reel/Frame 050403/0761 →
Assignment of Assignor's Interest Mar 20, 2020
From: SHISEIDO AMERICAS CORPORATION
To: SHISEIDO COMPANY, LIMITED
Reel/Frame 052203/0245 →
Assignment of Assignor's Interest Apr 5, 2022
From: MILLER, THOMAS A.; PAPAIOANNOU, NIKOLAOS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 059502/0854 →